CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Shandong Sinobioway Biomedicine Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Shandong Sinobioway Biomedicine Co Ltd
2005, No. 22, Keji South 12th Road
Phone: +86 75586950185p:+86 75586950185 SHENZHEN, GNG  255000  China Ticker: 002581002581
Business Summary
Shandong Sinobioway Biomedicine Co Ltd, formerly Zibo Wanchang Science & Technology Co Ltd, is a China-based company principally engaged in the manufacturing of pharmaceuticals. The Company is engaged in the business of interferon, nerve growth factor, biopharmaceutical contract research organization (CRO)/pharmaceutical contract development and manufacturing enterprise (CDMO), vaccines and pharmaceutical intermediates. The Company's main products include anferon, encyclopedia, Corona Virus Disease2019 vaccine and others. The Company distributes its products within domestic market.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202312/31/2022Yes----

Industries
SIC Code Description
2836 Biological products, except diagnostic substances
2834 Pharmaceutical preparations
2833 Medicinal chemicals and botanical products

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, General Manager JialinYue 54 8/22/2022 4/11/2022
Vice Chairman of the Board XiuyuanYu 60 10/13/2015 6/28/2011
Chief Financial Officer YangjunLiu 7/9/2022 7/9/2022
12 additional Officers and Directors records available in full report.

General Information
Number of Employees: 666 (As of 12/31/2022)
Outstanding Shares: 659,735,586 (As of 9/30/2023)
Shareholders: 48,437
Stock Exchange: SHE
Fax Number: +86 75586950185


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, April 24, 2024